文献速递性腺与生殖内分泌

超重和肥胖多囊卵巢综合征患者的肠道菌群与口服避孕药使用

Gut Microbiota and Oral Contraceptive Use in Overweight and Obese Patients with Polycystic Ovary Syndrome.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

一项前瞻性观察研究纳入17例超重/肥胖多囊卵巢综合征(PCOS)患者和15例年龄、体质指数匹配的健康对照女性,评估肠道菌群组成及口服避孕药(OC)使用3个月的影响。结果显示PCOS组基线瘤胃球菌科(Ruminococcaceae)相对丰度更高(P=0.006),α、β多样性和该菌科丰度在OC使用3个月后无显著变化。

要点

  • PCOS组基线瘤胃球菌科相对丰度高于健康对照(P=0.006)。
  • PCOS组与对照组基线α、β多样性无差异。
  • PCOS组OC使用3个月后肠道菌群组成特征无显著改变。

核心结论

  • 超重/肥胖PCOS女性瘤胃球菌科丰度增加,短期OC使用不改变该综合征患者肠道菌群的组成特征。

研究设计与样本

  • 前瞻性观察研究,在三级转诊医院开展,纳入17例超重/肥胖PCOS患者和15例年龄、体质指数匹配的健康对照女性。

主要发现

  • 基线时PCOS组与健康对照的α、β多样性无差异。
  • PCOS组瘤胃球菌科相对丰度高于健康对照(P=0.006)。
  • PCOS组接受OC并配合一般生活方式建议3个月后,α、β多样性未改变,瘤胃球菌科丰度未见显著变化。

关键数值与推荐

  • PCOS组瘤胃球菌科相对丰度较高(P=0.006);OC治疗3个月后该菌科无显著变化;α、β多样性基线和治疗后均无差异。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Polycystic ovary syndrome (PCOS) is a common and complex endocrine disorder. Emerging animal and human data point to various changes in microbiota that could be linked with the syndrome. However, the effects of therapeutic approaches on gut microbial composition in women with PCOS remain unknown. OBJECTIVE: We aimed to assess whether gut microbial composition is altered in PCOS and to determine the potential impact of oral contraceptive (OC) use on gut microbiota. DESIGN: Prospective observational study. SETTING: Tertiary referral hospital. PATIENTS AND OTHER PARTICIPANTS: The study included 17 overweight/obese patients with PCOS and 15 age- and body mass index-matched healthy control women. MAIN OUTCOME MEASURES: At baseline, clinical, hormonal, and metabolic evaluations and gut microbial composition assessment by 16S rRNA gene amplicon sequencing were performed for both groups. All measurements were repeated in patients after receiving an OC along with general lifestyle advice for 3 months. RESULTS: Alpha and beta diversity did not show a difference between patients with PCOS and healthy controls at baseline and remained unaltered after 3 months of OC use in the PCOS group. Relative abundance of Ruminococcaceae was higher in PCOS (P = 0.006) and did not show a significant change after treatment. CONCLUSION: Women with PCOS have an increased abundance of Ruminococcaceae, whereas short-term OC use does not alter compositional features of gut microbiota in the syndrome.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Eyupoglu ND, Ergunay K, Acikgoz A, et al. Gut Microbiota and Oral Contraceptive Use in Overweight and Obese Patients with Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2020. PMID: 32860695. doi:10.1210/clinem/dgaa600

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。